AskTheDate.com
Back to calendar

Halozyme Therapeutics, Inc. (HALO) Earnings

HALO reports earnings on Thursday, November 5, 2026

earnings report
November 5, 2026 · After Market Close
Q3 2026
Est. EPS: $2.30
Actual EPS: $2.28
EPS surprise: 27.58%
Company overview
Market Cap$14.9B
PriceUSD 130.91
P/E39.11
EPS (TTM)3.35
52-week high134.00
52-week low61.23
SectorHealth Technology
IndustryBiotechnology
Employees423
Buy me a coffee